, an opiosic developed by Upjohn's team in the 1970s, ACTS as a selective agonist for the -opioor with a Kd value of 5.3 nM and a kappa -opioor of 910 nM, about 7.5 x the potency of morne in animal models.
Signup today to claim your Discount. Get Started before it's too late!
